Dr. Almony is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2170 Midland Rd
Southern Pines, NC 28387Phone+1 910-295-2100Fax+1 910-295-3625
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 2005 - 2008
- Mercy Hospital (St Louis)Internship, Transitional Year, 2004 - 2005
- Keck School of Medicine of the University of Southern CaliforniaClass of 2004
Certifications & Licensure
- NC State Medical License 2012 - 2025
- MO State Medical License 2008 - 2015
- ND State Medical License 2010 - 2010
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Clinical Trials
- Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer Start of enrollment: 2006 Nov 01
- PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- 1 citationsDisease burden of neovascular age-related macular degeneration and diabetic macular edema.Arghavan Almony
The American Journal of Managed Care. 2023-06-01 - Treatment approaches for neovascular age-related macular degeneration and diabetic macular edema.Arghavan Almony
The American Journal of Managed Care. 2023-06-01 - 2 citationsCost impact of different treatment regimens of brolucizumab in neovascular age-related macular degeneration: A budget impact analysis.Zasim Azhar Siddiqui, Trupti Dhumal, Jay Patel, Traci LeMasters, Arghavan Almony
Journal of Managed Care & Specialty Pharmacy. 2022-12-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: